Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
www.virology-education.com
1ST CENTRAL AND EASTERN EUROPEAN MEETING ON
VIRAL HEPATITIS
WARSAW, POLAND • 22 - 23 JUNE 2015
AND CO-INFECTION WITH HIV
EVALUATION REPORT
2EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
EXECUTIVE SUMMARY
Over the last few years, the field of Viral Hepatitis and Co-infection has undergone several major changes. Therapeutic options are increasing and new data are becoming available incessantly which makes it challenging for healthcare professionals to stay informed and provide the best treatment possible for their patients. Also regional and local situations vary strongly and have a big impact on the decision making process of the clinician.
The Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV has been developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV. Much time was allocated to discussions and Q&A sessions in order to stimulate interaction and dialogue.
The content of the meeting and the invited lectures were very well received. The presentation of Dr Jonathan Schapiro at the special session on the optimal use of integrase inhibitors received the highest score of the entire meeting, with an average of 4.9 (on a scale of 5).
98% of the respondents indicated they will recommend this workshop to their colleagues and 100% indicated they plan to attend this workshop again next year.
The first edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV had 125 participants from 24 countries. The largest group, as expected, was from Poland ( 39).The below chart illustrates their professional background.
Professional Background
Clinician75%
Researcher14%
Other11%
The Organizing Committee and the Organizing Secretariat are pleased with the evaluation results of the 1st edition of this meeting and are looking forward to an even more successful second edition in 2016!
3EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
CONTENT
Content
Executive Summary .............................................................................. 2
Content ................................................................................................. 3
Introduction ........................................................................................... 4
Background .............................................................................................4
Target audience ......................................................................................4
CME Accreditation ..................................................................................4
Meeting Objectives ..................................................................................4
Learning Objectives ................................................................................5
Meeting Partners .................................................................................. 6
Acknowledgements .............................................................................. 7
Organizing committee........................................................................... 8
Scientific Committee ............................................................................ 9
Participants’ Feedback ........................................................................10
Impact ...................................................................................................10
General Event Experience ....................................................................10
Program ...............................................................................................11
Invited Lectures ....................................................................................11
Abstract - driven presentations ............................................................13
Participants’ Feedback ........................................................................14
Organization ..........................................................................................14
Publicity ................................................................................................14
Meeting demographics ........................................................................15
Number of Participants ........................................................................15
Professional background ......................................................................15
Conclusion ...........................................................................................16
List of Participants ...............................................................................17
4EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
INTRODUCTION
This is the evaluation report of the 1st Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV, held on 22 - 23 June 2015 at the Hilton Warsaw Hotel in Warsaw, Poland. The Organizing Commitee and the Organizing Secretariat highly value the opinion of the participants in order to further improve the quality of the workshop. Participants were asked to complete an evaluation form to share their opinion on several subjects.
BACKGROUNDThe Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV was initiated in 2014 and has been developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV.
The main objective of this meeting is to guide the Central/Eastern healthcare community regarding best practice for treating viral hepatitis and HIV co-infection and for stimulating collaborations to reach optimal patient care in this region.
FORMATThis 2-day international, abstract-driven scientific and educational meeting consisted of invited lectures, round-table discussions and oral abstract- and poster presentations. In order to ascertain an interactive workshop setting, much time was allocated to discussions.
TARGET AUDIENCEThe target audience of this workshop consists of healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastro-enterologists, hepatologists and others.
CME ACCREDITATIONThe 1st Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV was designated for a maximum of 10 hours of European external CME credits.
MEETING OBJECTIVES• To educate the practicing clinician on the best treatment options for Viral Hepatitis & Co-infection with HIV;
• To share cutting-edge information and translate to daily clinical practice;
• To provide a Central/Eastern-European platform for interaction and dialogue;
• To stimulate discussion among different disciplines;
• To build collaborations and develop research activities.
5EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
LEARNING OBJECTIVESAfter participating in this activity, the participants will:
• Have an understanding of the basic concepts of Viral Hepatitis and Co-infection;
• Have an insight into the spread of Viral Hepatitis in Central/Eastern Europe;
• Be updated on the latest developments in treatment strategies for mono- and co-infected patients;
• Have an understanding of the treatment challenges in Central/Eastern Europe;
• Be able to identify and adjust treatment strategies in different patient populations;
• Have an overview of the advantages and possibilities of new antivirals in HCV therapy.
6EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
MEETING PARTNERS
Societatea Română de Boli Infecţioase şi HIV/SIDA
7EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
ACKNOWLEDGEMENTS
Financial support for the 1ST CENTRAL AND EASTERN EUROPEAN MEETING ON VIRAL HEPATITIS AND CO-INFECTION WITH HIV has been provided by the following companies:
GOLD LEVEL
PLATINUM LEVEL
EXHIBITOR
BRISTOL - MYERS SQUIBB
8EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
ORGANIZING COMMITTEE
CHARLES BOUCHER, MD, PHD Erasmus Medical Center Rotterdam, the Netherlands
SVITLANA ANTONYAK, MD Academy of Medical Sciences Kiev, Ukraine
PAVEL KHAYKIN, MD MainFachArzt Frankfurt, Germany
VADIM RASSOKHIN, PHD Center for the Prevention and Control of AIDS and Inf. Diseases St. Petersburg, Russia
ANDRZEJ HORBAN, MD, PHD Hospital for Infectious Diseases Warsaw, Poland
JONATHAN SCHAPIRO, MD Sheba Medical Centre, Tel Aviv, Israel
JÜRGEN ROCKSTROH, MD University of Bonn, Germany
ADRIAN STREINU CERCEL, MD, PHD Nat. Institute for ID “Prof. Dr. Matei Bals”, Bucharest, Romania
ALICJA WIERCINSKA – DRAPAŁO, MD, PHD Medical University of Warsaw Warsaw, Poland
CIHAN YURDAYDIN, MD University of Ankara Medical School Ankara, Turkey
9EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
SCIENTIFIC COMMITTEE
Krasimir Antonov, MD, PhD ”St.Ivan Rilski” University Hospital, Sofia, Bulgaria
Dénes Bánhegyi, MD National Institute for Health Promotion, Budapest, Hungary
Saulius Caplinskas, MD, PhD Centre for Communicable Diseases and AIDS, Vilnius, Lithuania
Peter Jarcuska, MD, PhD J. Šafárik University, Košice, Slovakia
Brygida Knysz, MD, PhD Medical University of Wroclaw, Wroclaw, Poland
Mojca Maticic, MD, PhD University Medical Centre, Ljubljana, Slovenia
Cristina Popescu, MD, PhD National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Romania
Dalibor Sedlácek, MD, PhD University Hospital of Pilzen, Pilzen, Czech Republic
Tengiz Tsertsvadze, MD, PhD AIDS and Clinical Immunology Research Center, Tbilisi, Georgia
10EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
PARTICIPANTS’ FEEDBACK
IMPACTAttending this meeting has changed/will change my:
(Strongly) agree Average (Strongly) disagree
Thinking 92% 8% 0%
Behavior 69% 28% 3%
Overall, this meeting has enhanced my professional effectiveness
95% 5% 0%
As a clinician, i will improve my daily practice as a result of attending this meeting
88% 6% 6%
GENERAL EVENT EXPERIENCEExcellent /very much
agree
Average/neutral Fair /disagree
Overall event experience 98% 2% 0%
Opportunity of networking 93% 5% 2%
Content of the conference 98% 2% 0%
Time allocation for discussion 93% 7% 0%
Time allocation per presentation 95% 5% 0%
No commercial bias (product selling) perceived 95% 5% 0%
I would recommend this meeting to my peers 98% 2% 0%
I plan to attend this meeting next year 100% 0% 0%
11EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
PROGRAM
INVITED LECTURES
MONDAY 22 JUNE
08.30 h Registration, welcome coffee
Session 1: HIV-HCV Coinfection: Situation in Central-Eastern Europe
Local Situation in Poland Milosz Parczewski, MD, PhD, Pomeranian Medical University in Szczecin, Poland
Excellent Good Average Fair Poor
Topic is interesting 65% 31% 4% 0% 0%
Content is relevant to my work 54% 25% 17% 4% 0%
Local Situation in Ukraine Larisa Moroz, MD, PhD, Vinnitsa National Medical University, Ukraine
Excellent Good Average Fair Poor
Topic is interesting 47% 41% 12% 0% 0%
Content is relevant to my work 35% 28% 28% 7% 2%
Local Situation in Romania Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania
Excellent Good Average Fair Poor
Topic is interesting 49% 35% 14% 2% 0%
Content is relevant to my work 39% 33% 24% 4% 0%
Local Situation in Baltic Countries Saulius Caplinskas, MD, PhD, Lithuanian Center for Communicable Diseases and AIDS, Lithuania
Excellent Good Average Fair Poor
Topic is interesting 57% 35% 8% 0% 0%
Content is relevant to my work 43% 27% 24% 6% 0%
Local Situation in Czech and Slovak Republics Viktor Aster, MD, PhD, Charles University, Prague, Czech Republic
Excellent Good Average Fair Poor
Topic is interesting 49% 39% 12% 0% 0%
Content is relevant to my work 31% 35% 30% 4% 0%
Local Situation in Turkey Cihan Yurdaydin, MD, University of Ancara Medical School, Turkey
Excellent Good Average Fair Poor
Topic is interesting 47% 35% 8% 10% 0%
Content is relevant to my work 33% 29% 27% 9% 2%
Session 2: Management of Hepatitis C
Natural History of HCV Infection Krzysztof Simon, MD, PhD, Medical University of Wroclaw, Poland
Excellent Good Average Fair Poor
Topic is interesting 58% 26% 6% 8% 2%
Content is relevant to my work 48% 22% 22% 6% 2%
12EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
PROGRAM
Management of End-stage Liver Disease Massimo Puoti, MD, Niguarda Cà Granda Hospital, Italy
Excellent Good Average Fair Poor
Topic is interesting 65% 28% 4% 3% 0%
Content is relevant to my work 56% 27% 10% 7% 0%
State of the Art Treatment of HCV Sanjay Bhagani, BSc FRCP, Royal Free Hospital, UK
Excellent Good Average Fair Poor
Topic is interesting 87% 13% 0% 0% 0%
Content is relevant to my work 79% 16% 5% 0% 0%
An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe Mojca Maticic, MD, PhD, University Medical Centre, Ljubljana, Slovenia
Excellent Good Average Fair Poor
Topic is interesting 70% 30% 0% 0% 0%
Content is relevant to my work 66% 24% 10% 0% 0%
Management of Drug Drug Interactions David Back, PhD, University of Liverpool, United Kingdom
Excellent Good Average Fair Poor
Topic is interesting 87% 11% 2% 0% 0%
Content is relevant to my work 80% 9% 11% 0% 0%
TUESDAY 23 JUNE
Special session: Keys to Optimal Use of Integrase Inhibitors in Clinical Practice
Integrase Inhibitors: Virology and Resistance Charles Boucher, MD, PhD - Erasmus Medical Centre, Rotterdam, The Netherlands
Excellent Good Average Fair Poor
Topic is interesting 62% 36% 2% 0% 0%
Content is relevant to my work 59% 21% 15% 5% 0%
Speaker performance 67% 31% 2% 0% 0%
Clinically Relevant Drug Interactions Saye Khoo, MD, PhD, University of Liverpool, Liverpool, UK
Excellent Good Average Fair Poor
Topic is interesting 74% 26% 0% 0% 0%
Content is relevant to my work 74% 13% 8% 5% 0%
Speaker performance 82% 16% 2% 0% 0%
Translation to Clinical Management Jonathan Schapiro, MD, Sheba Medical Center, Tel Aviv, Israel
Excellent Good Average Fair Poor
Topic is interesting 86% 14% 0% 0% 0%
Content is relevant to my work 81% 7% 5% 7% 0%
Speaker performance 93% 5% 0% 2% 0%
13EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
PROGRAM
Session 3: Clinical Management of Hepatitis B Infection
Epidemiology of Hepatitis B in Central and Eastern Europe Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania
Excellent Good Average Fair Poor
Topic is interesting 60% 38% 2% 0% 0%
Content is relevant to my work 59% 21% 18% 2% 0%
State of the Art Treatment of Hepatitis B Maria Buti, MD, PhD, Hospital Vall d’Hebron, Spain
Excellent Good Average Fair Poor
Topic is interesting 65% 33% 2% 0% 0%
Content is relevant to my work 58% 33% 8% 3% 0%
Session 4: Clinical Management of Hepatitis C infection in Special Patient Populations
Acute Hepatitis C Infection Christoph Boesecke, MD, PhD, University of Bonn, Germany
Excellent Good Average Fair Poor
Topic is interesting 71% 19% 10% 0% 0%
Content is relevant to my work 60% 35% 5% 0% 0%
ABSTRACT - DRIVEN PRESENTATIONS
Average score
Excellent Good Average Fair Poor
Topic is interesting 45% 44% 8% 2% 0%
Content is relevant to my work 41% 37% 16% 4% 1%
14EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
PARTICIPANTS’ FEEDBACK
ORGANIZATIONExcellent/good Average Fair/poor
Content of electronic announcements 97% 3% 0%
Frequency of electronic announcements 97% 3% 0%
Information on coference website 97% 3% 0%
Online registration process 96% 4% 0%
Online abstract submission process 100% 0% 0%
Meeting venue 97% 3% 0%
Audiovisuals 97% 3% 0%
Onsite logistics 100% 0% 0%
Service level of Conference Secretariat 100% 0% 0%
PUBLICITYAttention was drawn to this meeting by: Influenced to attend this meeting by:
VE e-mail announcement
36%
VE Website26%
Internet search6%
Flyer at other
meetings3%
Via Partner organizations
16%
Colleague / word of mouth
13%
Meeting description
42%
Faculty27%
Scientific program
22%
Registration fee3%
Location3%
Other3%
15EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
MEETING DEMOGRAPHICS
NUMBER OF PARTICIPANTSThe first edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV had 125 participants from 24 countries. The largest group, as expected, was from Poland ( 39).
The geographical distribution of participants is as follows:
Albania 1
Belarus 2
Bosnia-Herzegovina 1
Belgium 2
Bulgaria 4
Croatia 2
Czech Republic 2
Estonia 1
Georgia 4
Germany 5
Israel 1
Italy 1
Latvia 2
Lithuania 4
Poland 39
Romania 12
Serbia 2
Slovenia 5
Spain 1
The Netherlands 1
Turkey 6
Ukraine 17
United Kingdom 9
USA 1
PROFESSIONAL BACKGROUNDMain activity Mainly employed by:
Clinician75%
Researcher14%
Other11%
University 36%
Hospital52%
Industry10%
Government1%
NGO1%
Area of expertise:
ID67%
Hepatology17%
Other16%
16EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
CONCLUSION
The overall opinion of the meeting was very positive, as can be deducted from the above scores. Participants were satisfied with the scientific content of the workshop as well as with the logistics and the format of the program. The Organizing Committee and the Organizing Secretariat are very pleased with the evaluation results of this workshop. The success and importance of this workshop have underlined the need for continuation. The second edition of the meeting will be held in Bucharest, Romania, in October 2016.
17EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
LIST OF PARTICIPANTS
Name, First name Institute Country
Ambrozaitis, Arvydas Vilnius University Lithuania
Andreychyn, Mykhaylo Ternopil Medical Institute Ukraine
Angeleski, Hristijan University Clinical Center Maribor Slovenia
Antonyak, Svitlana National Academy of Medical Sciences Ukraine
Arkliņš, Kaspars Gilead Sciences Latvia
Aster, Viktor Faculty Hospital Na Bulovce Czech Republic
Back, David University of Liverpool United Kingdom
Bander, Dorota Samodzielny Publiczny Wojewódzki Szpital Zespolony im. Marii Sklodowskiej – Curi
Poland
Barbulescu, Gabriel Bristol Myers Squibb Romania
Barska, Katarzyna Regional Specialist Hospital in Wroclaw, Research and Development Center
Poland
BASCIFTCI, HUSEYIN Gilead Sciences Turkey
Bhagani, Sanjay Royal Free Hospital United Kingdom
Bladowska, Joanna Wroclaw Medical University Poland
Boesecke, Christoph Universitätsklinikum Bonn Germany
Bondar, Borys AbbVie Biopharmaceuticals GmbH Ukraine
Boucher, Charles Erasmus Medical Center The Netherlands
Boucher, Charles Erasmus Medical Center The Netherlands
Bursa, Dominik Hospital for Infectious Diseases Poland
Buti, Maria Hospital Valle Hebron Spain
Caplinskas, Saulius Vilnius Infectious Diseases Hospital Lithuania
Carr, Val Gilead EMEA United Kingdom
Cielniak, Iwona Hospital for Infectious Diseases Poland
Cocuz, Elena Infections Hospital Brasov Romania
Cotirla, Mihaela Abbvie Romania
Czaja, Izabela Abbvie Poland
Czarnecki, Marcin Katedra i Klinika Chorób Zakaņnych Poland
Dakovic Rode, Oktavija University hospital for infectious diseases"Fran Mihaljevic" Zagreb
Croatia
Dembinski, Stan Axsan Poland
Dragneva, Sonya UH St. Ivan Rilski Bulgaria
Dressler, Stephan EATG - European AIDS Treatment Group Germany
Dyda, Tomasz Hospital for Infectious Diseases Poland
Fedorchenko, Sergii Institute of Epidemiology and Infectious Diseases "L.V.Gromashevskyi"
Ukraine
Ferrinho, Diogo Gilead Sciences Europe United Kingdom
Firlņg - Burkacka, Ewa PPL Poland
Fouche, Nicolas Gilead Sciences Europe United Kingdom
Gheorghita, Valeriu INBI Matei Bals Romania
Giedrojņ, Agata Abbvie Poland
Godlewska, Klaudia Wojewódzki Specjalistyczny Szpital im. Wł. Biegaņskiego w Łodzi
Poland
Gogia, Maka Georgian Harm Prevention Network Georgia
18EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
Gojak, Refet University Clinical Center Sarajevo Bosnia-Herzegovina
Gregorņiņ, Sergeja Clinical Center Ljubljana Slovenia
Griolet, Christophe Gilead Sciences Europe United Kingdom
Gronicz-Mleczko, Tamara Abbvie Poland
Hollanders, Els ViiV Healtcare Belgium
Horban, Andrzej Hospital for Infectious Diseases Poland
Iegorova, Tetiana Clinic No.5, Kiev Ukraine
Inci, Ayse ņstanbul Kartal Koņuyolu Yüksek ņhtisas Eņitim Ve Araņtırma Hastanesi
Turkey
Inglot, Małgorzata Katedra i Klinika Chorób Zakaņnych Poland
Iurko, Kateryna Kharkov national medical university Ukraine
Jaocha-Litwin, Justyna Wojewódzki Szpital Specjalistycznu im. J. Gromkowskiego
Poland
Jipa, Raluca INBI Matei Bals Romania
Kase, Kerstin West-Tallinn Central Hospital Estonia
Kerashvili, Vakhtang Center of infectious diseases and aids Georgia
Khaykin, Pavel MainFachArzt Germany
Khoo, Saye University of Liverpool United Kingdom
Knysz, Brygida Katedra i Klinika Chorób Zakaņnych Poland
Kocbach, Piotr PZOZ Poland
Koder, Marko Medicopharmacia d.o.o., Slovenia Slovenia
Kotecka , Kornelia Wojewódzki Specjalistyczny Szpital im. Wł. Biegaņskiego w Łodzi
Poland
Kozłowska, Joanna Hospital for Infectious Diseases Poland
Kurent , Anica General Hospital, Novo Mesto Slovenia
Kyrychenko, Tatyana UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY Ukraine
Latarska - Smuga, Dorota Abbvie Poland
Leszczyszyn-Pynka, Magdalena PUM Poland
Lipski, Kamil Gilead Sciences Poland Poland
Ludwiczak, Małgorzata Gilead Sciences Poland Poland
Łuksza - Biedula, Katarzyna Abbvie Poland
Lytvyn, Kateryna Dnipropetrovsk Medical Academy Ukraine
Matiņiņ, Mojca University of Ljubljana Medical Faculty Slovenia
Matkovskyi, Igor Vinnitsa AIDS Center Ukraine
Matulionytņ, Raimonda Vilnius University Lithuania
Mauss, Stefan Center for HIV & Hep.Gastroent. Germany
Mazur, Julita Gilead Sciences Poland
Mihailoviņ , Vesna Clinic for Infectious Diseases in Clinical center, Niš Serbia
Mikuła, Tomasz Hospital for Infectious Diseases Poland
Moroz, Larisa Vinnitsa National Medical Universty Ukraine
Nychyk, Natalia Ukraine
Parczewski, Miłosz Pomeranian Medical University Poland
Parris, Helen Gilead Sciences Europe United Kingdom
Pluta, Jan Medical University of Warsaw, Clinical Hospital Dzieciņtka Jezus
Poland
19EVALUATION REPORT 1st CEE Meeting on Viral Hepatitis and Co-infection with HIV 22 - 23 June 2015, Warsaw, Poland
Pluta, Magdalena Hospital for Infectious Diseases Poland
Pospieszynski, Jaroslaw Hospital for Infectious Diseases Poland
Potiy, Victoriia Donetsk National Medical University Ukraine
Pryshliak, Oleksandra Medical University Ivano - Frankovsk Ukraine
Puoti, Massimo Niguarda Ca'Granda Hospital Italy
Pyziak-Kowalska, Karolina Wojewódzki Szpital Zakaņny w Warszawie Poland
Ranin, Jovan Clinic for infectious and Tropical Diseases, Clinical center Serbia, Beograd
Serbia
Robaeys, Geert University of Hasselt Belgium
Rockstroh, Juergen University of Bonn Germany
Ross, Lisa ViiV Healthcare USA
Sargin, Fatma ņstanbul Göztepe Eņitim Ve Araņtırma Hastanesi Merdivenköy Polikliniņi
Turkey
Schapiro, Jonathan Sheba Medical Center Israel
Schonberger, Stanko Gilead Sciences Europe United Kingdom
Sedláņek, Dalibor Czech Republic
Siewaszewicz, Ewa Gilead Sciences Poland Poland
Simon, Krzysztof Wroclaw Medical University Poland
Siwak, Ewa PPL Poland
Smadu, Sebastian Victor Babes Hospital Romania
Smiechowicz, Gerard Gilead Sciences Poland Poland
Sobala-Szczygieł, Barbara Szpital nr I w Bytomiu, Oddzial Obserwacyjno-Zakaņny Poland
Soldatenko, Olga Belarus
Strashimirov, Dimitar Hospital of Infection Diseases Sofia Bulgaria
Streinu - Cercel, Anca Matei Bals Infectious Diseases Institute Romania
Streinu Cercel, Adrian Matei Bals Infectious Diseases Institute Romania
Tetradov, Simona Victor Babes Hospital Romania
Tiliscan, Catalin INBI Matei Bals Romania
Timchev, Andon Hospital of Infection Diseases Sofia Bulgaria
Ungurianu, Rodica INBI Matei Bals Romania
Valkov, Ivan UH St. Ivan Rilski Bulgaria
Voiniņ, Alina Vilnius Infectious Diseases Hospital Lithuania
WIERCIņSKA-DRAPAŁO, Alicja Hospital for Infectious Diseases Poland
Wnuk, Anita Samodzielny Publiczny Wojewódzki Szpital Zespolony im. Marii Sklodowskiej – Curi
Poland
Wójcik, Kamila WSS Poland
Yurdaydin, Cihan University of Ankara Medical School Turkey
Zabek, Piotr Hospital for Infectious Diseases Poland
Zakalashvili, Mamuka Clinic Mrcheveli Georgia
Zani, Zamir Regional Hospital "Omer Nishani", Gjirokaster Albania
Zekan, Sime University hospital for infectious diseases "Fran Mihaljevic", Zagreb
Croatia
Zubkiewicz-Zarņbska, Anna Klinka Chorób Zakaņnych, Chorób Watroby i Nabytych Niedoborów Odpornosciowyc
Poland
Zvirbulis, Viesturs Riga East Clinical Hospital, clinic "Infectology Centre of Latvia"
Latvia